SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,154,504 | +244.3% | 1,099,075 | +510.3% | 0.36% | +203.4% |
| Q2 2023 | $1,206,650 | -81.7% | 180,097 | -85.6% | 0.12% | -72.6% |
| Q3 2022 | $6,599,000 | +12.3% | 1,249,863 | -9.8% | 0.43% | +44.7% |
| Q2 2022 | $5,877,000 | +86.5% | 1,386,138 | +51.7% | 0.30% | +112.2% |
| Q1 2022 | $3,152,000 | -53.0% | 913,597 | -9.2% | 0.14% | -41.1% |
| Q4 2021 | $6,703,000 | -45.2% | 1,006,462 | -17.9% | 0.24% | -38.9% |
| Q3 2021 | $12,242,000 | -68.7% | 1,226,631 | -3.1% | 0.39% | -65.3% |
| Q2 2021 | $39,115,000 | -8.4% | 1,266,266 | +27.6% | 1.11% | -11.0% |
| Q1 2021 | $42,697,000 | -21.5% | 992,242 | -17.8% | 1.25% | -25.9% |
| Q4 2020 | $54,384,000 | – | 1,206,471 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
| Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
| EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
| Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
| 5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
| COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
| RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
| HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
| Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |